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Fatty Acid Concentration and
Phase Transitions Modulate Aβ
Aggregation Pathways
Pratip Rana1, Dexter N. Dean2, Edward D. Steen3, Ashwin Vaidya3, Vijayaraghavan
Rangachari2 & Preetam Ghosh 1
Aggregation of amyloid β (Aβ) peptides is a significant event that underpins Alzheimer disease (AD)
pathology. Aβ aggregates, especially the low-molecular weight oligomers, are the primary toxic
agents in AD and hence, there is increasing interest in understanding their formation and behavior.
Aggregation is a nucleation-dependent process in which the pre-nucleation events are dominated by
Aβ homotypic interactions. Dynamic flux and stochasticity during pre-nucleation renders the reactions
susceptible to perturbations by other molecules. In this context, we investigate the heterotypic
interactions between Aβ and fatty acids (FAs) by two independent tool-sets such as reduced order
modelling (ROM) and ensemble kinetic simulation (EKS). We observe that FAs influence Aβ dynamics
distinctively in three broadly-defined FA concentration regimes containing non-micellar, pseudomicellar or micellar phases. While the non-micellar phase promotes on-pathway fibrils, pseudomicellar and micellar phases promote predominantly off-pathway oligomers, albeit via subtly different
mechanisms. Importantly off-pathway oligomers saturate within a limited molecular size, and likely
with a different overall conformation than those formed along the on-pathway, suggesting the
generation of distinct conformeric strains of Aβ, which may have profound phenotypic outcomes. Our
results validate previous experimental observations and provide insights into potential influence of
biological interfaces in modulating Aβ aggregation pathways.
Aggregation of Aβ constitutes the central process in Alzheimer disease (AD) pathology. Brains of AD patients
contain large amounts of proteinacious plaques mainly comprised of insoluble Aβ fibril deposits. Monomeric
Aβ peptides (Aβ40 and Aβ42) spontaneously undergo aggregation towards large fibrils in a nucleation dependent manner. The effects of nucleation on aggregation dynamics have been extensively studied1–8 that point to a
key rate-limiting step for the formation of nucleus/nuclei9–13. Therefore, the dynamics associated with reactions
leading up to nucleation is critical for aggregation. Energetically, the pre-nucleation phase is nebulous with monomers and oligomers (dimers, trimers etc.) involved in a dynamic flux dominated by stochastic interactions14–16.
Furthermore, intrinsic disorder and amphipathic nature of Aβ facilitate multiple phase transitions and heterogeneous interactions during nucleation, making the process particularly sensitive to environmental factors such
as pH, ionic strength, temperature and other interacting partners17–22. This is significant because smaller, soluble
aggregates have emerged as the primary neurotoxic agents responsible for memory loss in AD23–26. Furthermore,
it is clear that oligomers may not be the obligatory intermediates to fibril formation, and that the oligomers can
also be populated along alternate pathways of aggregation (off-pathways)22, 27–32. Off-pathway oligomers differ
from those formed along the on-pathway resulting in multiple conformational variants with distinct biochemical
and cellular properties. Given the conformational diversity among oligomers, it is imperative to determine the
factors that affect dynamics involved in such oligomer formation to establish a framework of molecular mechanisms that better defines amyloid progression.
One class of biologically important interacting partners that affect Aβ pre-nucleation dynamics are the anionic surfactants such as fatty acids and lipids33–39. Lipids and fatty acids are profoundly important in physiological contexts as they are abundant in both brain tissues and CSF40, 41. The amphipathic Aβ peptide is known
to have strong affinity for membranes and hence, these interactions may affect the pre-nucleation dynamics.
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Figure 1. Schematic of the switching dynamics between the on- and off-pathways.

Several reports also demonstrate the effects of phospholipids on Aβ aggregation42–44. Similarly, both polyunsaturated (PUFAs) and saturated fatty acids are also known to have significant effects on the AD brain45, 46. Kumar
and co-workers have previously reported the generation of 4–5 mers and 12–24 mers from lauric acid along
a non-fibril formation pathway22. More importantly, using carbon chain lengths of C9-C12 fatty acids (FAs),
they established that below (non-micellar), near (pseudo-micellar) and above (micellar) their respective critical
micelle concentrations (CMCs), FAs generate Aβ oligomers or fibrils via distinct pathways22. A schematic of the
switching dynamics from on- to the off-pathway with increasing concentration of FAs is shown in Fig. 1. Here
the bold horizontal arrow signifies increasing FA concentration while the vertical arrows conceptually depict the
dynamical aggregation regimes of the system with the inclusion of monomeric Aβ. It can be observed that low
FA concentration involves the non-micellar phase where only the on-pathway reactions are active; while high
FA concentration (beyond the CMC) involves the micellar phase where only the off-pathway reactions are active
(with on-pathway being completely switched off). The middle phase of the FA concentration arrow denotes the
near-CMC (i.e., pseudo-micellar) phase and is the most interesting one; here, both on- and off-pathway reactions are active and the monomeric Aβ may form aggregated oligomers from both pathways simultaneously (as
denoted by the arrows).
In this report, we sought to understand the dynamics of heterotypic interactions between Aβ and FAs and
how phase transitions of FAs modulate Aβ aggregation. We first use a reduced order model (ROM) and a corresponding mathematical analysis rooted in a linear stability argument to identify the switching behavior from
on- to off-pathway in the presence of micellar interfaces. The ROM can be thought of as a toy-version of the far
more complex biophysical problem. However, despite considering only 4-species in this model, the ROM still
deals with a highly non-linear problem which captures the overall aggregation dynamics of the Aβ system and
allows for rigorous examination of features such as dynamic stability which would be intractable in the case of a
very fine grained model. Mathematical biologists consistently simplify complex biological problems to gain initial
insight into problems, to understand the nature of equilibria, stability, bifurcations in the larger system, before
venturing to speak of specific details which is the objective of the ROM. This analysis was used as the basis to further develop a more detailed model, which was built around the discoveries of the ROM and experimental data.
Secondly, using an ensemble kinetic simulation (EKS) model, we demonstrate that in three distinct
phase-transition regimes, FAs significantly and consistently modulate Aβ aggregation by altering the pathways.
These results are in agreement with the reported in vitro experimental observations, and provides detailed molecular insights into the heterotypic interactions between Aβ and FAs. These insights also reveal that generation of
conformationally-distinct oligomeric strains (produced by the oligomers involved in the on- and off-pathways)
are highly likely in physiological environments containing lipid and FA interfaces due to the dynamics involved
in the heterotypic FA-Aβ interactions.

Results

Stability analysis for a reduced order model (ROM).

We examined the sets of on- and off-pathway
reactions shown below. The model system considered is as follows:
k1+

A1 + FA − A1′
k1

(1)

k 2+

n ⋅ A1 − An
k2

(2)

k 3+

n ⋅ A1′ − An′
k3

(3)

where the reaction 2 is referred to the on-pathway, while reaction 3 is the off-pathway. In these reactions, A1
denotes the Aβ monomers while A1′ denotes the off-pathway monomers created in the presence of fatty acids, FA
(considering critical micelle concentration, CMC). An are the on-pathway oligomers while An′ are the off-pathway
oligomers made of n monomeric units. Finally, k i+ and k i− are the forward and backward rate constants of the
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Figure 2. The two panels in this figure depict the eigenvalues of the ROM Jacobian matrix B as a function of FA
concentration, denoted by the parameter α3. Case (a) shows the eigenvalues of the monomeric species B1 and B1′
as a function of α3, which reveals multiple switching in the strength of the stability of the two species. Panel (b)
shows the eigenvalues of the species Bn and Bn′. Here both the oligomers maintain their relative stability profile
for all α3. Note that Bis and Bi′s refer to the normalized versions of Ais and A′is, for i = 1, n.

corresponding reactions (i = 1, 2, 3). The details of the modeling methodology are elaborated in the Methods
section. We are aware that the on-pathway fibrils are considerably larger than the terminal species of the
off-pathway, i.e. size of (An) ≫ size of (A′n) or n ≫ n′. In the ROM analysis however, both pathways terminate at
the same value of n since we believe this to be sufficient to elucidate the competition between the two pathways in
our model. Since the only “bridge” from the on- to off-pathway is between the monomeric species, once the reaction chooses the path from A1 → An, the on-pathway dominates in the steady state (or vice-versa) and higher
order oligomer dynamics do not reveal anything more about the process. The asymmetric nature of the two pathways is however, considered in our follow-up analysis to understand detailed mechanistic phenomena.
Based on the results of our analysis presented in the Methods section, Fig. 2 shows the eigenvalues λi (i = 1–4),
of the Jacobian matrix for the mass action kinetic equations (18–21). These eigenvalues appear as a function of α3,
a normalized parameter which depend on the CMC and rate constants. The eigenvalues depict the rate of decay
of any perturbation to the stable, non-zero equilibria of the system of equations (18–21). It so happens that the
critical parameter α3 is key to determining whether the on-pathway or off-pathway is dominant. The Fig. 2 shows
some significant events in the dynamics of this system. As α3 is increased from zero, the real part of the eigenvalues λi are all negative, indicating that the equilibria are stable. When α3 < 1.0, we observe that λ2 < λ1. However,
when α3 > 1.0, it follows that λ2 > λ1 indicating an exchange in the magnitude of the stability. For α3 > 1.0, the
species B1 (dimensionless version of A1) dominate in magnitude and also become more stable than B1′ (dimensionless version of A1′), indicating a transcritical-like bifurcation at α3 = 1.0.
Note that in the dynamical systems literature, transcritical bifurcation refers to a stable equilibrium and an
unstable equilibrium which exchange stabilities with respect to some parameter47. In our model system, the
switching of stabilities is revealed by α3, which, by its definition, contains the ratio of the forward to backward rate
constants for this reaction, as well as the fatty acid concentration which enhances the formation of the off-pathway
species. Figure 3(b) shows the rate of reformation of the species Bn and Bn′, which is slower than the monomeric
species.
Another interesting phenomenon that occurs in this system is a discontinuity in the eigenvalues or second
switching which occurs at around α3 = 1.87 (see Fig. 3(a)). The Table 1 in the Supplementary Information captures the variety of switching behaviors and changes in behavior of the ROM system when different parameters
(rate constants) are varied. At this stage, the biophysical implication of this second critical point is unclear to us
although it is most certainly a symptom of the high nonlinearity of the system.
We explore the effect of n on our system, for 1 ≤ n ≤ 20. Our analysis reveals significant changes to the stability of the system as n varies; in particular, the eigenvalues λ1 and λ2 show some dramatic changes with n. For
1 ≤ n < 12, multiple switching points (at least two) were observed with λ2 eventually being more negative than λ1,
i.e. off-pathway eventually becomes more stable for sufficiently large α3. However, for 12 ≤ n ≤ 20, the on-pathway
eventually becomes more stable. The physical significance of the multiple switching, in particular the one beyond
α3 = 1 still eludes us and it remains to be verified if this an indication of some underlying bifurcation in the system
or is simply an artifact of the nonlinear system or an indication of some nucleation type event observed in our
previous work using similar methods48.
The results of our stability analysis with support from the Nash equilibrium for this system (see Methods
section), allows us to draw the following conclusions: (i) The simplified, though highly nonlinear system of ROM
equations with 4-species captures the essential dynamics of the Aβ system and can help explain the switching dynamics considering only the CMC; (ii) The non-dimensional parameter α3 is seen to be the key control
parameter in this analysis indicating that FA concentration, along with the ratio of the rate constants along this
Scientific REPOrTS | 7: 10370 | DOI:10.1038/s41598-017-09794-x
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Figure 3. The figure depicts the population of all four species, monomers and oligomers, in the ROM as a
function of time. In its initial state, only the on-pathway monomers (B1) are taken to exist which reveals itself in
the declining trend of B1s and an increase in the other species over time. The evolution of the monomers and
+
aggregates is depicted for four different values of α 3 = k1 −FA while the remaining parameters in these cases
k1
correspond to the baseline case α1 = β1 = 0.1, α2 = β2 = 100 and n = 4. The inset shows a zoomed in version of
the same plot to clearly show the initial phase of evolution. In each of the figures, the black filled circles
represent B1, the open circles represent B1′, The x-shaped symbols corresponds to Bn and open triangles, to Bn′.

Carbon chain
diameter (nm) at
lengths of fatty acids above-CMC range

diameter (nm) at
near-CMC range

C9

2

14–16

C10

2.7

13.5–19

C11

3.2

16–22.5

C12

3.8

19–27

Table 1. Size difference between FApm and FAm for different carbon chain lengths of FAs determined by
dynamic light scattering.
“bridge” reaction pathway determine the ultimate fate of the system. (iii) The presence of a second, discontinuous
switching of eigenvalues at α3 ≥ 1.87 potentially indicates a different biophysical phenomenon occurring along
the off-pathway implicating the involvement of additional species that may play an important role in the FA
dynamics. To explore the dynamics between on- and off-pathways of Aβ aggregation, we then conducted a more
detailed ensemble simulation using chemical kinetics under varying concentration of FAs.

Ensemble kinetic simulation (EKSs) on Aβ-FA dynamics. In order to further investigate the dynam-

ics between the on- and off-pathways in the presence of FAs, we used the EKS approach. EKS approach involves
numerical ordinary differential equation (ODE)-based simulations that encompasses ensembles of the dynamic
species involved in the reaction flux. Fundamental aspects of EKSs were used in the on-pathway model that we
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Figure 4. Experimental and simulated data at control and below CMC concentration. (a) For C12 FAs; Black
squares: Experimental ThT intensity for on-pathway; Black line: simulated ThT intensity for on-pathway; Red
triangles: Experimental ThT intensity for below-CMC set-up; Red line: simulated ThT intensity for below-CMC
set-up; (b) Below-CMC experimental ThT intensity and simulated intensities for C9-C11; (c) Below-CMC semilog concentration ratio for A4′ /A4, i.e., the 4-mers from off-pathway and on-pathway respectively considering
monomer entry rates; the oligomer concentration were recorded at 50th, 100th and 200th hours for C12 fatty
acids; (d) Oligomer concentration ratios between below CMC ( AiFAn) and on-pathway (Ai) set-ups designated
by AiFAn /Ai ; Red: (A1 at below-CMC)/(A1 at control); Blue: (A4 at below-CMC)/(A4 at control); Yellow: (A8 at
below-CMC)/(A8 at control); Green: (A12 at below-CMC)/(A12 at control).

had previously reported10, 48. In this report, we have expanded the EKS model to simulate various phase-transition
regimes of FAs and Aβ, especially along off-pathway (elaborated in the Methods section). Before modeling onand off-pathway dynamics, it is imperative to simulate the phase-transitions of FAs during micelle formation.
We specifically chose three concentration regimes at which FAs show distinct phase changes: low concentrations
where the FAs are non-micellar (FAn), near their CMCs where they are pseudo-micellar (FApm), and high concentration where they are fully micellar (FAm). We conjecture the nomenclature, pseudo-micelles to define the
dynamic state between a non-micelle and a micelle, which seemed to affect Aβ in a distinct way22. The hydrodynamic radii (Rh) estimates of FApm and FAm indicated that the former is ~6–7 times larger than the latter, confirming the loosely-held, amorphous state of FApm (Table 1).
Dynamics in non-micellar phase - Aβ–FAn interactions. First, for the control experiment in the absence of FAs
(on-pathway reactions, exclusively), we find the forward rate constants during the nucleation stage (knuon) is
considerably lower than the forward rate constant (kfbon) of elongation stage, as expected (Fig. 4(a)). The simulated data showed good correlation with the experimental data with an R2 value of 96.2, and an equally good
agreement in the lag times (Fig. 4(a)) for C12, as well as C9-C11 FA data (Fig. 4(b)). The estimated rate constants for control, i.e., on-pathway, are shown in Supplementary Table 2 in Appendix-B under Supplementary
Information. Secondly, in the presence of FAn, on-pathway reactions still dominate due to the absence of micelles
(or pseudo-micelles) in the solution. We hypothesize that FAns interact with Aβ and catalyze aggregation by altering the rate constants along the on-pathway by a factor of K, resulting in a change in the final fibril concentration.
The corresponding set of reactions for this model are shown in Appendix-C under Supplementary Information.
We obtain the value of K < 1 for the best fit with the experimental data pointing to a slowdown in the elongation
stage of the on-pathway (Supplementary Table 3 in Appendix-C under Supplementary Information).
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Fatty acid

Experimental concentration
CMC (mM) in (mM) from ref. 22

R2

Predicted pseudo-micelle
concentration (μM)

C12

7

5

95.5

11

C11

22

20

92.5

16

C10

50

50

88.8

45

C9

85

100

91.1

8

Table 2. Relation of CMC, deviation from CMC with Experimental Fatty acid concentration, and predicted
pseudo-micelle concentration; additionally reported are the R2 fit between simulation and experimental ThT
intensity.

The simulations of Aβ interactions with C12 FAn when compared to the on-pathway fibril growth characteristics, provided two important observations. First, the overall aggregation was augmented with the introduction
of FAn, consistent with the overall ThT intensity observed in experiments (Fig. 4(a); red). Second, the third phase
of fibril growth curve (i.e., the slower growth phase towards saturation subsequent to the exponential growth
phase) was delayed for a considerable amount of time with C12 FAn (as opposed to the on-pathway), despite no
change in the lag time (Fig. 4(a)). We hypothesize these effects are caused by the introduction of FAn, which modulate the on-pathway rate constants. To test this hypothesis, we systematically analyzed the effects that FAn may
have on the rates of on-pathway reactions at critical times of the aggregation process. First, the forward rate constants during the pre-nucleation stage was altered (increased/decreased) by a factor of K, which did not fit the
fibril growth curve for the C12 FAn case and concomitantly could not validate this behavior (data not shown).
Next, upon varying the forward elongation rate constant (kfbon), a small decrease in the forward elongation rate
constant render higher ThT intensity with delayed saturation time, and without changing the lag time. This suggests that the addition of FAn molecules effectively decrease the forward elongation rate constants. According to
the Lee’s and our own on-pathway models48, 49, the elongation stage (ie. A12 + A1  A12; A12 + A2  A12; …
and A12 + A11  A12) does not lead to the increase in ThT intensity directly as these reactions may not increase
the number of ThT binding sites significantly to augment fluorescence intensities. Hence, a decrease in the elongation rate constant essentially extends the duration of the pre-nucleation stage, although without increasing the
lag time. This subsequently could increase the formation of pre-nucleated on-pathway aggregates (specifically
12 mers, i.e., A12s) resulting in higher ThT intensity/fibril growth. The increased number of A12s resulting from
these reactions then react with one another as well as the on-pathway oligomers during the pre-nucleation stage
(monomers to 11 mers, i.e., A1–A11) to generate higher order aggregates with concomitant higher ThT intensities.
The predicted K value for different initial FAn concentrations is shown in Supplementary Table 3 in Appendix-C
under Supplementary Information. Similar corresponding plots for ThT vs simulations for C9-C11 FAn are shown
in Fig. 4(b). The high R2 values obtained for the fits (Supplementary Table 3) suggest that FAns promote
on-pathway fibrils by a slightly different mechanism as compared to the Aβ aggregation in the absence of FAs.
Hence, as shown in Fig. 4(c), the ratio of A4′/A4 is effectively zero.
We further consider two hypothetical but physically relevant scenarios in which varying rates of entry of Aβ
monomers and FAs were considered as opposed to a fixed concentration50. The reaction models for this scenario
were then minimally modified to consider these additional entry rates as variables to evaluate the oligomer concentration dynamics. As expected in Fig. 4(c), the interaction of FAn with Aβ generated no off-pathway oligomers
due to the absence of micelles or pseudo-micelles. Only on-pathway aggregates were formed exclusively, although
by a slightly different mechanism. Based on these results, we determine that FAns decrease the rates during the
fibril elongation stage along the on-pathway, which seems to hold good for each type of FA used (C9-C12).
In (Fig. 4(d)), we report the oligomer ratios (of the same size) between the control and FAn set-ups. We considered four oligomers for this test: A1, A4, A8, A12; in each case, these ratios rise above the value of 1, showing that
the presence of more below-CMC oligomers than on-pathway oligomers in the system as time increases. Note
that these were generated from two stand-alone simulations, one for the control and the other one for FAn as in
both cases only on-pathway oligomers are produced. The results clearly suggest that the FAn scenario produces
more oligomers (and possibly more fibrils) with time which supports the experimental observation of increased
ThT intensity for FAn. Additionally, as expected the ratios are smaller for larger oligomers; this is simply because
of the reaction order as fewer oligomers of larger size are formed in the system. Thus our reaction hypothesis of
a slowdown of the elongation stage in the presence of FAns, although counter-intuitive, accurately validates the
experimental observations of increased ThT intensity.
Dynamics in pseudo-micellar phase - Aβ/FApm interactions. FA concentration around the CMC increases the
concentration of FApm in the bulk solution, the presence of which shifts the reaction flux towards predominantly
off-pathway as established experimentally22, 51 (Fig. 1). As the forward elongation rate constant becomes crucial
only at the later phase of the on-pathway reactions, the effect of K was neglected here. This allowed us to assume
that effectively all FAs convert to FApms and thus making the effects of free FAs during the on-pathway elongation
stage negligible. The predicted rate constants from the control experimental data were used here for the
on-pathway set of reactions, and the parameter space was iterated to only estimate the rate constants involving
off-pathway reactions. Thus, our combined on- and off-pathway model was able to explain all the experimental
observations in the presence of FApm (corresponding R2 values are reported in Table 2 for C9-C12 FAs).
Furthermore, previous reports identified that 12–24 mers (LFAOs) are the predominant species generated in the
presence of C12 FApm22, 51. Our simulations predict the presence of multiple conformers within the oligomer of a
Scientific REPOrTS | 7: 10370 | DOI:10.1038/s41598-017-09794-x
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specific size (strains) as observed before52. The 12–24 mer LFAOs show conformational dynamics (represented as
F1′ and F1″ here), wherein the F1′, and not F1″, is able to associate with itself. Note that both species (F1′ and F1″)
correspond to 12–24 mer LFAOs and we considered up to four-fold lateral associations between them to form F4′
which are essentially 48–96 mers as previously established52. Such F4′ LFAOs then undergo a secondary fragmentation to produce four F1″ which are not allowed to laterally associate thereby making the 12–24 mers as the predominant species. This is due to subtle yet distinct structural differences between the two 12–24 mer LFAOs53. In
our model, we identified that lateral association and fragmentation are both critically important in Aβ/FApm
reaction dynamics, which ultimately explains the formation of stable oligomers of size 12–24 i.e., F1″. The predicted concentration of pseudo-micelles are shown in Table 2 while the predicted rate constants and shown in
Supplementary Table 4 in Appendix-D under Supplementary Information.
Overall simulation of the ThT intensity data for FApm regime yielded good correspondence with the experimental results for C12 (Fig. 5(a); green). We obtained a high R2 value and nearly similar correspondence with the
experimental lag time and saturation time for C12 as well for C9-C11 FAs (Fig. 5(b)). The comparative concentration dynamics of off-pathway and on-pathway aggregates in the presence of FApm are shown in Fig. 5(c–f) for C12
fatty acid. Figure 5(e) is the data for constant FApm and varying Aβ monomer entry rates while Fig. 5(f) is the data
obtained for constant monomers and varying FApm entry rates. In our model, for the sake of simplicity and comparison, we considered aggregates of similar sizes from both on- and off-pathway. We observe that the on-pathway
oligomers A4, A7 and A12 show delayed emergence (Fig. 5(c)). It is noteworthy that A4 emerges rapidly, and saturates before decreasing in concentration. This behavior is due to the elongation of oligomers by A12s that occurs
along the on-pathway, which form larger fibrils at the cost of A4 consumption. Along the off-pathway, aggregates
′ show expected characteristics of being formed rapidly initially before saturating (Fig. 5(d)). It is
A4′, A8′ and A12
′ oligomers to form the
important to note that the elongation in the off-pathway leads to F1′ consuming A4′ and A12
12–24 mers as discussed previously. Such F1′s then associate to form F4′ which are seen in greater quantities
towards the beginning with their concentration decreasing with time, which is likely due to fragmentation of high
molecular weight aggregates. Finally, most of the FApm dynamics leads to the formation of the F1″ with time, which
becomes the predominant ThT positive species in the system. This dynamics is further corroborated by incorporation of physiologically relevant monomer entry rates into the system (Fig. 5(d)). Here, the dynamics show more
conclusively the dominance of the F1″ oligomer in the system with increasing time followed by A8′ and A4′. In order
to verify the potential fragmentation identified by our simulation, we investigated this possibility experimentally
by incubating Aβ and C12 FA near its CMC (Fig. 6). The results indicate that incubation rapidly results in the
formation of aggregates corresponding to 50–60 nm diameter within one hour of incubation (Fig. 6(a) and (b)).
However, after two hours of incubation, the size of the aggregates decreased to 10 nm diameter. No more change
in the aggregate size was observed even after 48 h (data not shown). This phenomenon was also observed in the
aggregate size monitored by immunoblotting (Fig. 6(c)), and supports the possibility of fragmentation of aggregates as predicted by the EKS model predictions.
Figure 5(e) and (f) show the ratio of the oligomer distributions for C12 fatty acids considering constant entry
rates of Aβ monomers with fixed initial FApm concentration (Fig. 5(e)) and FApm into the system for fixed initial
monomer concentration (Fig. 5(f)), respectively, as described before for FAn. These plots illustrate the switching
behavior between the on- and off-pathways as predicted by the ROM stability analysis (Figs 2 and 3). For example,
we can observe that for negligible monomer or FApm entry rates, the on-pathway is active, but the switching
occurs quickly to off-pathway when the monomer entry rate is about 0.001 × 100 μM h−1 (Fig. 5(e)). This switching effect is however faster when the FApm entry rate is considered as shown in Fig. 5(f) (the amplitude of the
F1″/A12 ratio is higher in the latter case). Also, the ratios are higher after 50 h of incubation as compared to after
100 or 200 h (Fig. 5(e) and (f)). This suggests that either the F1″ concentration decreases with time or the A12
increases with time or both cases happen simultaneously. As shown in Fig. 5(d), the increase in A12 is more pronounced that that in F1″ concentration with time (note that both concentration increase with time) resulting in a
decrease in the recorded ratio with time. Nevertheless, we can conclude that generally the switch to off-pathway
is extremely fast with higher FApm entry rates being a more crucial factor than an increase in the monomer entry
rates for the observed effect.
Comparing the FApm ThT intensity plots (Fig. 5(b)), we additionally observe that the concentration of FApm
significantly affects the behavior of aggregation. For example, higher the FApm concentration present in the system (correlates with smaller fatty acid chain length), more the saturation is delayed for the ThT growth curve. As
expected, our predicted FApm concentration is highest near the CMC, and the concentration starts to decrease
when total FA concentration is either increased or decreased. The predicted FApm concentration for each fatty
acid chain length at the near CMC zone experiments is shown in Table 2. Note that the prediction for the C9 case
shows a small deviation primarily because the experiment was done at a 100 mM concentration while the actual
CMC was 85 mM, i.e., a deviation of 17.6%.
Dynamics in micellar phase - Aβ − FAm interactions. The above-CMC regime (FAm) only produces A4′ along the
off-pathway that do not seem to aggregate any further due to the stabilization by the micelles22 (Fig. 7(a)).
Therefore, the corresponding reaction model only considers the pre-nucleation stage in the off-pathway.
Furthermore, the A4′ oligomers do not bind to ThT and hence, are invisible to this assay. This complicates the
precise predictions of A4′ concentrations and direct correlation with the experimental data. Therefore, we could
not estimate the accurate rate constants for FAm. It is noteworthy that we assumed the off-pathway reactions in the
presence of FApm also undergoes similar pre-nucleation stage reactions besides others. The rate constants of the
pre-nucleation stage from FApm data was used for this simulation to determine the dynamics of A4′ production. As
shown in Fig. 7(b) and (c), one could observe that A4′ is generated rapidly accompanying a switching to the
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Figure 5. Experimental and simulated data at near CMC concentration: (a) and (b). Comparisons of the
concentration of important oligomers between on- and off-pathways considering monomer, pseudo-micelle
and micelle entry rates into the system: (c–f); the oligomer concentration were recorded at 50th, 100th and 200th
hours for C12 fatty acids. (a) Green circles: Experimental ThT intensity for near-CMC set-up; Green line:
simulated ThT intensity for near-CMC set-up; Black squares: Experimental ThT intensity for on-pathway; Black
line: simulated ThT intensity for on-pathway; (b) Near-CMC experimental ThT intensity and simulated
intensities for C9-C11; (c) Oligomer concentration plot for C12 fatty acids at the near-CMC range with 25 μM
monomers (i.e., A1); (d) Oligomer concentration for C12 fatty acids at the near-CMC range considering
0.1 μM/h rate of entry of A1 into the system; (e) Near-CMC semi-log concentration ratio for F1″/A12, i.e., the
structurally distinct 12-mers from off-pathway undergoing secondary fragmentation and the 12-mers from onpathway respectively considering monomer entry rates; (f) Near-CMC semi-log concentration ratio for F1″/A12,
considering pseudo-micelle (denoted by FApm) entry rates.

off-pathway, even with negligible monomer or micelle entry rates. As the A4′ formation presumably involves a
concerted single step reaction, the concentration profile is different from its on-pathway counterpart, A 4.
Specifically, as micelle entry rate increases, number of micelles in the system also increases such that the A4′ con-
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Figure 6. Dynamics of Aβ interaction with C12 FA. (a) Size of the aggregates estimated by DLS after 15 (black)
and 30 (red) minutes of incubation at 37 °C, along with data after 1 (orange), 1.5 (blue), 2 (pink), 2.5 (green)
and 3 (yellow) hours of incubation, respectively. (b) Variations in diameter (nm) for each time point, calculated
from data in panel (a). (c) SDS-PAGE with immunoblotting of LFAO formation at 37 °C from 0 to 24 hours,
respectively. The amount loaded into each lane was kept constant at 1.1 μg.

Figure 7. Experimental (points) and simulated (lines) ThT intensities at (a) Above-CMC concentration; Black:
on-pathway; Blue line: simulated ThT intensity at above-CMC set-up. (b) Above-CMC semi-log concentration
ratio for A4′ /A4, i.e., the 4-mers from off-pathway and on-pathway respectively considering monomer entry
rates; (c) Above-CMC semi-log concentration ratio for A4′ /A4, considering micelle (denoted by FAm) entry rates.

centration increases much faster than that of the A4 concentration as shown in Fig. 7(c). However, Fig. 7(c) suggests that for a fixed initial micelle concentration, and as the Aβ monomer entry increases, the ratio of A4′ /A4 goes
towards saturation. This is potentially due to reduction in the number of micelles available for accommodating
Aβ on the micellar surface.

Discussion

The results reported here by two independent methods (ROM and EKS) reaffirm the experimental observations that FAs modulate Aβ aggregation. Specifically, the following significant conclusions can be drawn from
this work: (a) interactions of Aβ with non-micellar FAs (FAn) generate predominantly high molecular weight,
on-pathway aggregates. (b) Interactions of Aβ with FAs near the latter’s CMC (FApm) generate predominantly low
molecular weight oligomers (12–24 mers) along off-pathway along with some minor quantities of on-pathway
fibrils. (c) Interactions of Aβ with high concentrations of FAs (FAm; above their CMCs) exclusively generate
off-pathway 4–5 mer oligomers without any fibrils suggesting that the on-pathway was completely turned off.
Perhaps most significantly, simulations from both ROM and EKS, as well as the previously demonstrated
experimental evidence have identified that both concentration and phase-transitions of FAs dictate switching
of Aβ aggregation pathways. Furthermore, the report demonstrates that under three distinct phases, FAn, FApm,
and FAm, the FAs not only modulate Aβ aggregation pathways but also promote low molecular weight oligomers,
which are increasingly known to be the main pathogenic species in AD and other related neurodegenerative
disorders. Specifically under pseudo-micellar conditions, where FApm undergoes a distinct phase transition, they
preferentially promote and stabilize low-molecular weight oligomers. The ability of certain phases of FAs, or in
general any biological surfactants, to promote the formation of low molecular weight, off-pathway presents high
significance in AD pathology. This is because oligomers generated in this manner could lead to the formation of
various toxic ‘conformeric strains’ of Aβ aggregates, which could manifest in distinct phenotypic manifestations
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Figure 8. On- and Off-pathway switching dynamics at near-CMC and above-CMC zones considering Aβ and
pseudo-micelle entry rates for C12 fatty acid. (a) switching dynamics at near-CMC zone at the 50th hour; (b)
switching dynamics at near-CMC zone at the 200th hour; (c) switching dynamics at above-CMC zone at the 50th
hour; (d) switching dynamics at above-CMC zone at the 200th hour.

observed in AD. Indeed, Dean et al., have shown that LFAOs, which are generated in the presence of C12 FAs,
are able to propagate morphologically distinct fibrils and caused excessive cerebral amyloid angiopathy (CAA) in
transgenic mice brains, which was absent in similar reactions seeded with on-pathway fibrils52.
Mechanistically, simulations reported here have revealed a deeper understanding of Aβ-FA interactions. Some
of the salient dynamics involved in the modulation of Aβ aggregation by FAs in distinct phases include: (i) in the
presence of FAn, the free FAs seem to slow the kinetics of elongation (or post-nucleation) stage along the
on-pathway, (ii) in the presence of FAm, aggregation does not proceed beyond A4′ (or A5′) likely due to the stabilization of Aβ by FAm as Aβ-FAmm complex. Further investigation of this complex by molecular dynamics based
studies to infer why such complexes cannot aggregate is on-going and will be reported at a later date, and (iii) in
′ , and
the presence of FApm, Aβ forms A4 during the pre-nucleation phase followed by a slower progression to A12
elongation to form 12–24 mers denoted by F1′. Association of F1′ to form F4′, which is thermodynamically unstable,
leads to a fragmentation to form F1″ as supported by experimental evidence (Fig. 6). The most likely possibility is
that the F1″ are structurally distinct and different from F1′ that are trapped in some kinetic minimum along the
off-pathway as thought to be22, 51, which renders them incapable of aggregating further.
In addition to these insights, EKS model also considered a physiological scenario in which instead of constant
amount or Aβ or FAs, a constant influx of Aβ monomers as well as pseudo-micellar and micellar FAs were considered. Incorporating specific entry rates for Aβ and FAs, we observe that the presence of pseudo-micellar phase
influences the switching of pathways more than that induced by the monomers. However, we observed that even
a slight increase in the entry rates of either FA or Aβ is enough to switch the dynamics preferentially towards the
off-pathway. This is evident in Fig. 8, which shows a surface plot which considers the monomer and FApm/FAm
rates. The corresponding oligomer concentration ratios along off- and on-pathway show that the on-pathway is
active only when FApm entry rates are very low (Fig. 8(a) and (b)). After 50 h of incubation, off-pathway is predominantly activated for the highest FApm entry rate and low monomer entry rates. In other words, all monomers
entering the system are consumed by FApm leaving little scope for on-pathway reaction to occur. However, after
Scientific REPOrTS | 7: 10370 | DOI:10.1038/s41598-017-09794-x
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Table 3. A sample game-theoretical payoff matrix to depict the on- and off-pathway competition. The cells
highlighted in blue represent the Nash equilibrium.

200 h, off-pathway is most active when both FApm and monomer entry rates are high resulting in most monomers
being consumed by the FApm. The scenario is bit different for FAm, where the off-pathway is most active when
both monomer and FAm entry rates are high both after 50 and 200 h (Fig. 8(c) and (d)). The dynamics seems to be
more stable after 200 h than after 50 h, as oligomer concentrations saturate by then. However after 50 h, a switch
to off-pathway happens only with sufficiently high Aβ monomer and FAm entry rates, and there may be a critical
point in this entry rate for both that would dictate whether a switch to the off-pathway occurs or not. In later
times though (200 h, for example), there is a higher propensity of the system to switch to the off-pathway even
with lower monomer or micelle entry rates.
Overall, this report has brought forth several interesting observations on the dynamics of Aβ-FA interactions,
which seems to depend critically on the concentration and phase of FAs. Furthermore, the switching dynamics in
conjunction with the constant infusion of Aβ monomers and FAs in their distinct phases illustrate the potential
of biological interfaces to influence Aβ into forming several different conformationally distinct aggregates. Such
conformeric strains could then influence phenotypic outcomes in AD pathology.

Methods

Experimental.

Preparation of large fatty acid-derived oligomers (LFAOs). C12:0 fatty acid (5 mM) with
50 mM NaCl was added to freshly purified Aβ monomer (50 μM) buffered in 20 mM Tris, pH 8.0, and kept at
37°C in quiescent conditions. Separate reactions were started in a staggered fashion such that at the time of data
collection, the sample would reach the desired time point.
Dynamic light scattering (DLS). DLS data was collected using a Zetasizer Nano S instrument (Malvern, Inc.,
Worcestershire, UK). At each time point, DLS was collected by averaging 24 runs of 5 s each with a pre equilibration time of 30 s. This average was used to determine the diameter (nm) using the volume (%) function. For
determining micelle size without Aβ, stock concentrations of C9:0, C10:0, C11:0, and C12:0 were diluted to the
appropriate concentration in 50 mM NaCl buffered in 20 mM Tris, pH 8.0.

SDS-PAGE with immunoblotting. LFAO preparations were staggered in start such that at the time of initiating
SDS-PAGE experiments, each sample was at the desired time point. Samples were diluted into 1X Laemmli loading buffer with 1% SDS, and loaded onto 4–20% BioRad TGX gels without boiling. Pre-stained MW markers
(Novex Sharp Protein Standard, Life Technologies) were run in parallel for MW determination. Proteins were
transferred to 0.2 μm nitrocellulose membrane (BioRad) and boiled for 1 min in a microwave oven in 1X PBS,
followed by blocking for 1.5 h in 1X PBS containing 5% nonfat dry milk with 1% tween 20. Blots were then probed
overnight at 4 °C with a 1:6000 dilution of Ab5 monoclonal antibody, which detects amino acids 1–16 of Aβ. Blots
were then incubated with a 1:6000 dilution of anti-mouse, horseradish peroxidase conjugated secondary antibody
and developed with ECL reagent (Thermo Scientific).

Reduced Order model (ROM).

The system of differential equations corresponding to Eqns 1 determines
the evolution of the 4 species ( A1 , A1′ , An′ , An′) and are given by
dA1
= nk 2−An − nk 2+A1n + k1−A1′ − k1+A1FA
dt

(4)

dA1′
= nk 3−An′ − nk 3+A1n − k1−A1 + k1+A1FA
′
′
dt

(5)

dAn
= − k 2−An + k 2+A1n
dt

(6)

dAn′
= − k 3−An′ + k 3+A1′ n
dt

(7)

The above equations are better suited for analysis in non-dimensional form. If we chose the characteristic
concentration and time as A0 (the equilibrium concentration of monomers) and 1− , respectively, then the dimenk1
sionless variables can be defined as follows:
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B1 =
α1 =

A1
A′
A
A′
; B1′ = 1 ; Bn = n ; Bn′ = n
A0
A0
A0
A0

k 2−
k 2+A0n −1
k +FA
k−
k +A n −1
; α 3 = 1 − ; β1 = 3− ; β 2 = 3 −0 ;
− ; α2 =
−
k1
k1
k1
k1
k1

(8)

The corresponding dimensionless differential equations, in terms of dimensionless time ‘s’, now can be written as
dB1
′
= nα1Bn − nα 2B1n + B1 − α 3B1
ds

(9)

′

dB1
′
′
′
= nβ1Bn − nβ 2B1n + α 3B1 − B1
ds

(10)

dBn
= α 2B1n − α1Bn
ds

(11)

′

dBn
′
′
= β 2B1n − β1Bn
ds

(12)

Equilibrium points. In the equations (4–7), if we consider the limit (k1+, k1−, FA) → (0, 0, 0), then the
off-pathway dynamics is turned off, leaving only the reaction
k 2+

n ⋅ A1 − An .
k2

However, the on-pathway cannot be switched off and always persists. In this case the equilibrium solution is
1/n 

+
.
given by the pair A0 , k 2− A0


k2

Turning our attention now to the more general case of the non-dimensional equations (9–12), the equilibrium
points, Be = (B1,e , B1,′ e , Bn , e , Bn′ , e ) can be obtained by the vanishing of the equations (9–12). Solving for these four
simultaneous equations, we obtain the following relations, in terms of the equilibrium concentration B1,e

( )

Bn , e =

α2 n
β αn
B1,e ; B1,′ e = α 3B1,e ; Bn′ , e = 2 3 B1,ne .
α1
β1

(13)

The subscript e indicates that these species are in equilibrium.
It should also be noted that if one treats the on- and off-pathway dynamics as a “competition” in accordance
with the term used in game-theory54, 55, then the equilibrium Be
= BNash , e is nothing but the Nash equilibα3=1

rium of the system given by



α
β
BNash , e : = B1,e , B1,e , 2 B1,ne , 2 B1,ne 


α1
β1

(see Fig. 3 for an example of such an equilibrium). This equilibrium exists only at α3 = 1 which also will be seen to
have special significance in terms of the stability of the system. It follows that when α3 > 1, then the off-pathway
species dominate creating more equilibrium concentrations of B1,′ e and for α3 < 1, on-pathway dominates resulting in greater production of B1,e .
We define k+ = k1+FA and k− = k1− so that the former leads to off-pathway and the latter to on-pathway.
Table 3 below points to a sample case of the various strategies in the competition between the two pathways with
the pay-off for each “strategy” given by the equilibrium concentrations.
Time evolution of the different species. The system of equations (4–7) were solved using the Matlab ode45 function.
A sample solution is shown in Fig. 2 corresponding to initial conditions: B1(0) = 2, B1′(0) = Bn(0) = Bn′(0) = 0,
α1 = β1 = 1, α 2 = β 2 = 1 and n = 4. Also, here α 3 = 1 which results in B1, e = B1,′ e .
Linear stability analysis. To study the stability of the four species, we linearly perturb the system which is mathematically represented by
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Bn = Bn , e + εX n

(16)

Bn′ = Bn′ , e + εYn

(17)

then the linearized set of differential equations for the perturbations, at o(ε) becomes
dX1
= nα1X n − n2α 2B1,ne−1X1 + Y1 − α 3X1
ds

(18)

dY1
= nβ1Yn − n2β 2α 3n −1B1,ne−1Y1 − Y1 + α 3X1
ds

(19)

dX n
= nα 2B1,ne−1X1 − α1X n
ds

(20)

dYn
= β 2α 3n −1B1,ne−1Y1 − β1Yn
ds

(21)

which can be expressed in operator form with the perturbation matrix, B given by
−n2α B n −1 − α
1
nα1 0 

2 1,e
3


n −1 n −1
2

−
−
1
0
α
n
β
α
B
n
β

3
2 3
1,e
1

B = 


−α1 0 
0
nα 2B1,ne−1



0
β 2α 3n −1B1,ne−1
0 −β1

The stability of the equilibrium is found from computing the eigenvalues, λi (i = 1, 2, 3, 4) of the matrix B. This
is best done numerically. In the figures below we discuss the results of the computations. In particular, the term
α3 is varied throughout the analysis since it captures a significant dynamical feature of this problem; the switching
from on-pathway to off-pathway. Over all, we choose the following ranges for our parameters:
10−10 ≤ α i , βi ≤ 1010 for i = 1, 2. Also, 1 ≤ n ≤ 20 and 1 ≤ B1, e ≤ 20. We begin with the base case defined by the
choice α1 = β1 = 0.1, α 2 = β 2 = 100, n = 4 and B1,e = 1 and then study the sensitivity of the system and our
results to each of the parameters.

Ensemble Kinetic Simulations (EKS) of on- and off-pathways. Experimental observations and model
assumptions. The detailed simulations and subsequent analysis are based on prior work where the in-vitro
experiment using the non-esterified fatty acids of chain length C9 to C12 revealed a few crucial characteristics of
Aβ42 aggregation22:
1. At FA concentration less than CMC range (FAn), only on-pathway aggregates were produced. Furthermore
an increase in ThT intensity than the control experiment was detected.
2. At near CMC (FApm), off-pathway fibrils of length 12–24 mers were noticed with very few fibrils being
produced leading to the conclusion that the on-pathway was almost switched off.
3. At FA concentration higher than CMC (FAm), off-pathway oligomers of length 4–5 mers were observed
while no fibrils were produced, i.e., the on-pathway was switched off completely.
Before establishing a proper modeling of the off-pathway, we wish to explore the formation of micelles first.
Ideally, CMC is the concentration of the surfactants (here, FAs) in the solution from where the micelle formation
starts. Therefore, if high concentration of surfactants are introduced into the solution (FAm), it directly forms
micelles. At FAn and FApm concentrations, ideally there should not be any micelles present in the solution whereas
at FAm range, almost all of the FAs should convert into micelles. As discussed earlier, at FApm, the FAs loosely form
pseudo-micelles that are six-seven times larger than regular micelles. It can hence be hypothesized that as the FA
concentration is increased beyond the CMC, extra FA molecules bind to the pseudo-micelles, which may then
undergo structural change to form more stable and compact structured micelles (i.e., L) that were considered in
the ROM model.
Based on the experimental observations, we make the following considerations to formulate the underlying
reaction mechanism.
1. At FAn range, only on-pathway reactions take place, as in this zone no micelles are present in the solution.
We assume that the presence of FAs have catalytic effects in altering the rate constants of the on-pathway
with a factor of K resulting in a change in the final fibril concentration; the corresponding set of reactions
are shown in Appendix-C under Supplementary Information.
2. At FAm concentrations, both on-pathway and off-pathway occur simultaneously; however, as seen in the
ROM model, the existence of micelles can switch the Aβ monomers more towards the off-pathway
aggregates. We further assume that one micelle binds four Aβ monomers at once to form the off-pathway
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species A4′; such A4′ oligomers cannot aggregate any further. This is because our experimental observations
at FAm range point to the formation of A4′ s which do not aggregate to form fibrils.
3. Similarly at FApm range, both on- and off-pathway reactions occur simultaneously. The reaction mechanism for A4′ oligomer formation is similar as in the previous step. However, in this case the oligomer A4′
further aggregates to form 12–24 mers.
On-pathway reaction model. The on-pathway reaction model is motivated by our previous works in
refs 9, 10, 47, 52, 56. Here, two different sets of reactions are considered. Firstly, the Aβ monomers form higher
order aggregates (A12) through monomer addition and eventually form fibrils; the modeling abstraction considers A12 as fibrils, F. These reactions mainly depend on the monomer concentration and are slow being termed as
pre-nucleation. Next, the higher order oligomers (A12) react with the monomers and other on-pathway aggregates
(A2, …, A11) and get elongated. The rates of these reactions depend on both monomer and fibril concentration.
The pre-nucleation stage is slower, whereas the elongation phase is rapid, thereby causing the sigmoidal growth
of the fibril concentration over time. The nucleation number of on-pathway reactions is taken as 12 as reported in
ref. 48; these reactions are shown in Appendix-B under Supplementary Information.
FAn reaction model. At the FAn range, we assume the reactions to be exactly similar to the on-pathway model;
however the rate constants for each phase of the sigmoidal ThT growth curve were varied by a factor of K. The
corresponding reaction model is shown in Appendix-C under Supplementary Information.
FAm reaction model. The proposed off-pathway reaction set is quite different from the on-pathway model and
motivated by the experimental observations. In this model, at FAm range, the four Aβ monomers directly convert
into the off-pathway oligomer ( A4′) by reacting with micelles, L. These A4′ s can not able elongated any further.
These reactions are shown in Appendix-E under Supplementary Information.
FApm reaction model. The modeling of off-pathway reactions at FApm zone is more challenging however; there
are no existing models for off-pathway reactions at this zone. Furthermore, the behavior of aggregation, although
sigmoidal, is much dissimilar than the on-pathway reaction in terms of the faster time-scale involved; the formation of 12–24 mers in this zone exhibit considerably less lag time and saturation time. We consider the following
′)
reactions at this range. In the first stage denoted as primary nucleation, the A4′ form higher order oligomers ( A12
′ further elongates with the intermediate oligomers
by monomer addition (i.e., adding A1). In the next stage, A12
′ ) to form higher order oligomers (F1′); this stage is termed as the elongation stage. Note that a F1′ is a mod( A4′– A11
eling abstraction and is of variable length; it’s length ranges from 16 mers to 23 mers (considering the addition of
′ each to A12). This results in a 6-fold increase in the oligomer size hosted by the pseudo-micelles as
A4′ , ... , A11
compared to the micelles (which can only host upto A4′, whereas pseudo-micelles can host 23 mers) and is consistent with the experimental observations on the diameters of pseudo-micelles and micelles. We next consider
such F1′ oligomers to laterally associate and create bigger oligomers (F4′); we term this stage as lateral association.
As experimentally validated in Fig. 6, there is approximately a four-fold increase in oligomer size towards the
′ and F1′; hence it is highly
beginning of the FApm dynamics after which the oligomer size goes down to that of A12
likely that the laterally associated F4′ undergoes a secondary fragmentation into the lower order oligomer F1″.
It is noteworthy that F1″ is a structurally different species than F1′; the latter can laterally associate while the
former cannot. This assumption was necessary to fit with the experimentally observed ThT kinetics data.
Considering the secondary fragmentation to produce F1′ instead of F1″ could not correlate the simulation plots
with the experimentally observed ThT dynamics. The set of near-CMC reactions are shown in Appendix-D under
Supplementary Information.
Thus, the model at the near-CMC range deals with several rate constants and parameters. There are four rate
constants for on-pathway reactions: (i) forward and backward rate constants of pre-nucleation reaction (knuon,
knuon_) from the on-pathway; (ii) forward and backward rate constants of elongation reactions (kfbon, kfbon_) from
the on-pathway; (iii) forward and backward rate constants of pre-nucleation in the off-pathway (kcon and kcon_);
(iv) forward and backward rate constants of nucleation reactions (knouff, knouff_); (v) forward and backward rate
constants of elongation reactions (kfboff, kfboff_) (vi) forward and backward rate constants of lateral association reactions (keloff, keloff_); (vii) forward and backward rate constants of secondary fragmentation (kfagoff, kfagoff_); (viii) the
fatty acid effect on the on-pathway rate constant parameter, K; and finally (ix) the pseudo-micelle concentration:
p. Note that, the estimation of the pseudo-micelle concentration from the CMC values of fatty acids poses a different problem and needs controlled experimentation; however, it is biophysically not possible to exactly measure
the pseudo-micelle concentration. We could only measure the diameter of pseudo-micelles. Hence we considered
p as a free parameter along with the other rate constants to estimate the pseudo-micelle concentration.
Parameter estimation. It is difficult to estimate the proper rate constant values of all these parameters at
once. Hence, we follow our divide and conquer strategy from ref. 10 to determine all the rate constants step by
step. First, we matched the experimental data of the control experiment with the simulation considering the
on-pathway reaction setup only and estimated the four rate constants involved in the on-pathway reactions.
Subsequently, we used these values in the combined on-off-pathway model to estimate all the additional rate
constants. More precisely, our simulation involves the steps below:
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1. First, determine the rate constants for the on-pathway reactions from control experiment data.
2. Estimate the parameter K for the FAn experimental data by using the estimated on-pathway rate constants.
3. Estimate the rate constants of off-pathway aggregation with FApm experimental data utilizing the estimated
on-pathway rate constants above.
4. Validate the formation of off-pathway oligomers ( A4′) in FAm concentration using all the estimated rate
constants.
We first calculated the reaction flux for all reactions at a particular stage; then using these reaction fluxes, the
differential equations for the rate of change of concentration is formulated for each oligomer. Next, these differential
equations were solved using MATLAB’s ode solver and the R2 value between the simulated curve and experimental
data was calculated for the different rate constant combinations. We solved these differential equations for various
rate constant combinations with each rate constant ranging from 10−5 to 105 and the pseudo-micelle concentration
p from 1 to 100 μM with multiples of 5. After that, these rate constants were manually fine-tuned to better match
the experimental data and obtain better rate constant estimates. The best-fitted simulation parameters are taken as
estimated rate constants of these reactions; each of these parameters are reported in the Appendices under the corresponding reaction models. Moreover, all the rate constants estimated here by fitting with experimental ThT intensity
plots required a mapping of the cumulative effects of the concentration of higher order ThT positive oligomers to the
ThT values; such mapping is explained in Appendix-F in the Supplementary Information.
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